Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also earned a Bachelor of Arts in journalism and was editor-in-chief of her undergraduate newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have three young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

General Medicine

Optimal Time Identified for Monoclonal Antibody Infusions in Patients With COVID-19

Estie Mermelstein, MSN, FNP-BC

October 5, 2021

Researchers sough to assess the effects of treatment with a monoclonal antibody infusion in patients hospitalized with COVID-19.

Lung Infection

Outcomes of Heparin vs Standard Care Thromboprophylaxis in Patients With COVID-19

Estie Mermelstein, MSN, FNP-BC

September 23, 2021

Investigators conducted a multiplatform trial to compare the effects of therapeutic-dose heparin with standard care thromboprophylaxis for the treatment of patients hospitalized with moderate COVID-19.

Critical Care

Clinical Efficacy, Safety of Janus Kinase Inhibitors in Patients Hospitalized With COVID-19

Estie Mermelstein, MSN, FNP-BC

September 20, 2021

Investigators conducted a meta-analysis of 3 randomized controlled trials that compared the clinical safety and efficacy of janus kinase inhibitors with placebo or standard care for the treatment of patients with COVID-19.

General Pulmonology

Local and Systemic Adverse Effects of Vaccinated Individuals Reported in the COVID Symptom Study App

Estie Mermelstein, MSN, FNP-BC

September 8, 2021

Investigators compared adverse effects of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines reported in the COVID Symptom Study App with those reported during phase 3 trials.

Pneumonia

Rapid PCR Bests Traditional Culture in Correlation of Clinical Variables in Pneumonia

Estie Mermelstein, MSN, FNP-BC

August 23, 2021

Researchers assessed the performance of a pneumonia panel in relation to clinical measures and outcome variables.

Lung Infection

RSV and Parainfluenza Increase Hospitalization Risk in HIV-Exposed Infants

Estie Mermelstein, MSN, FNP-BC

August 4, 2021

As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.

General Pulmonology

At the Intersection of 2 Pandemics: The Impact of COVID-19 on HIV

Estie Mermelstein, MSN, FNP-BC

July 15, 2021

A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.

General Pulmonology

Cancer Patients Respond Well to COVID-19 Vaccine

Estie Mermelstein, MSN, FNP-BC

June 30, 2021

Investigators evaluated antibody response to the Pfizer BioNTech COVID-19 vaccine in patients actively undergoing treatment for cancer.

Lung Infection

Moderna, Pfizer-BioNTech COVID-19 Vaccines Provide Immunity in Pregnant Women

Estie Mermelstein, MSN, FNP-BC

June 23, 2021

Investigators assessed response to vaccination with the Moderna or Pfizer-BioNTech COVID-19 vaccines in pregnant and nonpregnant lactating women.

Pneumonia

Patients With CAP at Increased Risk for CV Events and Poor Clinical Outcomes

Estie Mermelstein, MSN, FNP-BC

April 19, 2021

Investigators assessed the cumulative incidence of acute cardiovascular complications during hospitalization for community-acquired pneumonia in internal medicine units.

Next post in Pneumonia